CoChat

TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis

Open access

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Abstract

CONTEXT: Interpretation of thyroid function tests during pregnancy is limited by the generalizability of reference intervals between cohorts due to inconsistent methodology. OBJECTIVE: (1) To provide an overview of published reference intervals for thyrotropin (TSH) and free thyroxine (FT4) in pregnancy, (2) to assess the consequences of common methodological between-study differences by combining raw data from different cohorts. METHODS: (1) Ovid MEDLINE, EMBASE, and Web of Science were searched until December 12, 2021. Studies were assessed in duplicate. (2) The individual participant data (IPD) meta-analysis was performed in participating cohorts in the Consortium on Thyroid and Pregnancy. RESULTS: (1) Large between-study methodological differences were identified, 11 of 102 included studies were in accordance with current guidelines; (2) 22 cohorts involving 63 198 participants were included in the meta-analysis. Not excluding thyroid peroxidase antibody-positive participants led to a rise in the upper limits of TSH in all cohorts, especially in the first (mean +17.4%; range +1.6 to +30.3%) and second trimester (mean +9.8%; range +0.6 to +32.3%). The use of the 95th percentile led to considerable changes in upper limits, varying from -10.8% to -21.8% for TSH and -1.2% to -13.2% for FT4. All other additional exclusion criteria changed reference interval cut-offs by a maximum of 3.5%. Applying these findings to the 102 studies included in the systematic review, 48 studies could be used in a clinical setting. CONCLUSION: We provide an overview of clinically relevant reference intervals for TSH and FT4 in pregnancy. The results of the meta-analysis indicate that future studies can adopt a simplified study setup without additional exclusion criteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgac425

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Study selection flowchart.
Figure 1. Study selection flowchart.CC BY-NC-ND · PubMed Central
Figure 2. Overview studies systematic review trimester 1. *Reference intervals calculated with individual participant data in consortium. ○, iodine sufficiency; ▽, mild-to-moderate iodine deficiency; △, excessive iodine status. Reference intervals calculated in cohorts with fluctuating or excessive iodine status are listed in gray.
Figure 2. Overview studies systematic review trimester 1. *Reference intervals calculated with individual participant data in consortium. ○, iodine sufficiency; ▽, mild-to-moderate iodine deficiency; △, excessive iodine status. Reference intervals calculated in cohorts with fluctuating or excessive iodine status are listed in gray.CC BY-NC-ND · PubMed Central
Figure 3. Overview studies systematic review trimester 2. *Reference intervals calculated with individual participant data in consortium. ○, iodine sufficiency; ▽, mild-to-moderate iodine deficiency; △, excessive iodine status. Reference intervals calculated in cohorts with fluctuating or excessive iodine status are listed in gray.
Figure 3. Overview studies systematic review trimester 2. *Reference intervals calculated with individual participant data in consortium. ○, iodine sufficiency; ▽, mild-to-moderate iodine deficiency; △, excessive iodine status. Reference intervals calculated in cohorts with fluctuating or excessive iodine status are listed in gray.CC BY-NC-ND · PubMed Central
Figure 4. Overview studies systematic review trimester 3. *Reference intervals calculated in individual participant data in consortium; ○, iodine sufficiency; ▽, mild-to-moderate iodine deficiency.
Figure 4. Overview studies systematic review trimester 3. *Reference intervals calculated in individual participant data in consortium; ○, iodine sufficiency; ▽, mild-to-moderate iodine deficiency.CC BY-NC-ND · PubMed Central
Figure 5. Results meta-analyses trimester 1. 1Defined as the weighted average change in reference limits across cohorts. 2Calculated using 2.5th to 97.5th percentiles, excluding prepregnancy thyroid disease, use of thyroid hormone–altering medication, and TPOAb positivity; the total number of participants in subgroups differs based on availability of data on additional exclusion criteria. 3Defined as prepregnancy diabetes mellitus. 4Defined as BMI > 30 kg/m2 at time of intake. 5Pregnancy by in vitro fertilization. 6Defined as gestational diabetes, gestational hypertension, pre-eclampsia, preterm birth, and/or small for gestational age.
Figure 5. Results meta-analyses trimester 1. 1Defined as the weighted average change in reference limits across cohorts. 2Calculated using 2.5th to 97.5th percentiles, excluding prepregnancy thyroid disease, use of thyroid hormone–altering medication, and TPOAb positivity; the total number of participants in subgroups differs based on availability of data on additional exclusion criteria. 3Defined as prepregnancy diabetes mellitus. 4Defined as BMI > 30 kg/m2 at time of intake. 5Pregnancy by in vitro fertilization. 6Defined as gestational diabetes, gestational hypertension, pre-eclampsia, preterm birth, and/or small for gestational age.CC BY-NC-ND · PubMed Central
Figure 6. Results meta-analyses trimester 2. 1Defined as the weighted average change in reference limits across cohorts. 2Calculated using 2.5th to 97.5th percentiles, excluding pre-pregnancy thyroid disease, use of thyroid hormone altering medication, and TPOAb-positivity; the total number of participants in subgroups differs based on availability of data on additional exclusion criteria. 3Defined as prepregnancy diabetes mellitus. 4Defined as BMI >30 kg/m2 at time of intake. 5Pregnancy by in vitro fertilization. 6Defined as gestational diabetes, gestational hypertension, pre-eclampsia, preterm birth, and/or small for gestational age.
Figure 6. Results meta-analyses trimester 2. 1Defined as the weighted average change in reference limits across cohorts. 2Calculated using 2.5th to 97.5th percentiles, excluding pre-pregnancy thyroid disease, use of thyroid hormone altering medication, and TPOAb-positivity; the total number of participants in subgroups differs based on availability of data on additional exclusion criteria. 3Defined as prepregnancy diabetes mellitus. 4Defined as BMI >30 kg/m2 at time of intake. 5Pregnancy by in vitro fertilization. 6Defined as gestational diabetes, gestational hypertension, pre-eclampsia, preterm birth, and/or small for gestational age.CC BY-NC-ND · PubMed Central
Figure 7. Results meta-analyses trimester 3. 1Defined as the weighted average change in reference limits across cohorts. 2Calculated using 2.5th to 97.5th percentiles, excluding prepregnancy thyroid disease, use of thyroid hormone altering medication, and TPOAb-positivity; the total number of participants in subgroups differs based on availability of data on additional exclusion criteria. 3Defined as prepregnancy diabetes mellitus. 4Defined as BMI >30 kg/m2 at time of intake. 5Pregnancy by in vitro fertilization. 6Defined as gestational diabetes, gestational hypertension, pre-eclampsia, preterm birth, and/or small for gestational age.
Figure 7. Results meta-analyses trimester 3. 1Defined as the weighted average change in reference limits across cohorts. 2Calculated using 2.5th to 97.5th percentiles, excluding prepregnancy thyroid disease, use of thyroid hormone altering medication, and TPOAb-positivity; the total number of participants in subgroups differs based on availability of data on additional exclusion criteria. 3Defined as prepregnancy diabetes mellitus. 4Defined as BMI >30 kg/m2 at time of intake. 5Pregnancy by in vitro fertilization. 6Defined as gestational diabetes, gestational hypertension, pre-eclampsia, preterm birth, and/or small for gestational age.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 54

Metadata

Authors
Osinga, J. A. J., Derakhshan, A., Palomaki, G. E., Ashoor, G., Männistö, T., Maraka, S., Chen, L., Bliddal, S., Lu, X., Taylor, P. N., Vrijkotte, T. G. M., Tao, F.-B., Brown, S. J., Ghafoor, F., Poppe, K., Veltri, F., Chatzi, L., Vaidya, B., Broeren, M. A. C., Shields, B. M., Itoh, S., Mosso, L., Popova, P. V., Anopova, A. D., Kishi, R., Aminorroaya, A., Kianpour, M., López-Bermejo, A., Oken, E., Pirzada, A., Vafeiadi, M., Bramer, W. M., Suvanto, E., Yoshinaga, J., Huang, K., Bassols, J., Boucai, L., Feldt-Rasmussen, U., Grineva, E. N., Pearce, E. N., Alexander, E. K., Pop, V. J. M., Nelson, S. M., Walsh, J. P., Peeters, R. P., Chaker, L., Nicolaides, K. H., D’Alton, M. E., & Korevaar, T. I. M.
Affiliations
  • Erasmus MC (NL)
  • Brown University (US)
  • Harris Birthright Research Centre for Fetal Medicine (GB)
  • Oulu University Hospital (FI)
  • Mayo Clinic (US)
  • Ruian People's Hospital (CN)
  • University of Copenhagen (DK)
  • Cardiff University (GB)
  • Amsterdam Public Health (NL)
  • Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University; Anhui Provincial Key Laboratory of Population Health & Aristogenics , Hefei, Anhui , China
  • Sir Charles Gairdner Hospital (AU)
  • Department of Research and Innovation, Shalamar Institute of Health Sciences , Lahore , Pakistan
  • Université Libre de Bruxelles (BE)
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California , CA 90089 , USA
  • University of Exeter (GB)
  • Máxima Medisch Centrum (NL)
  • Hokkaido University (JP)
  • Pontificia Universidad Católica de Chile (CL)
  • First Pavlov State Medical University of St. Petersburg (RU)
  • Federal Almazov North-West Medical Research Centre (RU)
  • Isfahan University of Medical Sciences (IR)
  • Pediatric Endocrinology Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital , Girona , Spain
  • Harvard University (US)
  • Shifa International Hospital (PK)
  • University of Crete (GR)
  • University of Oulu (FI)
  • Toyo University (JP)
  • Anhui Medical University (CN)
  • Institut d'Investigació Biomèdica de Girona (ES)
  • Memorial Sloan Kettering Cancer Center (US)
  • Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and clinical Sciences, Copenhagen University , Copenhagen , Denmark
  • Boston University (US)
  • Brigham and Women's Hospital (US)
  • Tilburg University (NL)
  • University of Glasgow (GB)
  • The University of Western Australia (AU)
  • King's College London (GB)
  • Columbia University Irving Medical Center (US)
Corresponding author
Osinga, Joris A J
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2022-07-21
Volume
107
Issue
10
Pages
2925-2933
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4286491818
Cited by
54
References
38
Citations by year
2026: 13 · 2025: 14 · 2024: 12 · 2023: 13 · 2022: 2
FWCI
1.46
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc-nd)
  • Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
Funders
Netherlands Organization for Scientific Research (grant 401.16.020)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
thyroid-stimulating hormone, free thyroxine, thyroid function tests, pregnancy, reference values, thyroid peroxidase antibodies, methodological heterogeneity, thyroid function in pregnancy
MeSH terms
Female, Humans, Iodide Peroxidase, Pregnancy, Reference Values, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis. https://app.cochat.ai/papers/10.1210/clinem/dgac425
The paper
Osinga, J. A. J., Derakhshan, A., Palomaki, G. E., Ashoor, G., Männistö, T., Maraka, S., Chen, L., Bliddal, S., Lu, X., Taylor, P. N., Vrijkotte, T. G. M., Tao, F.-B., Brown, S. J., Ghafoor, F., Poppe, K., Veltri, F., Chatzi, L., Vaidya, B., Broeren, M. A. C., . . . Korevaar, T. I. M. (2022). TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.